2.06 - 2.2
1.14 - 2.59
Join Discuss about OTIC with like-minded investors
Next Dividend Date
Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière's disease, hearing loss, and tinnitus.
CEO: David Weber
HQ: 4796 Executive Dr San Diego, 92121-3090 California